SOLUTIONS FOR A WORLD WITHOUT BORDERS WHERE WOMEN THRIVE

Helen is the founder and director of The Foremothers Café, a Swedish American Women’s History Museum and Cultural Center in Virtual Reality.
She’s a published author and has written several historical novels, including Sour Milk in Sheep’s Wool, a story about women’s rights movements in Sweden at the turn of the 20th century, which inspired The Foremothers Café.

Helen is the managing director for Ready Player Golf, which raises money for charity by playing golf in VR.

Dee Dee Chainey-Jones is a storyteller creating immersive experiences across folklore and heritage. As Director of The Cultural Futures Foundry, she leads The Cultural Futures Hub VR Community Centre, hosting events on inclusive engagement and digital storytelling. Her recent VR projects include Enter the Maltaverse for European Heritage Days 2025 and an XR retelling of Sir Gawain and the Green Knight at the Williamson Art Gallery. Founder of #FolkloreThursday, Dee Dee connects global audiences through shared myths and is co-author of the Treasury of Folklore series. 

Website: https://culturalfuturesfoundry.com/ 

LinkedIn: https://www.linkedin.com/in/dee-chainey-jones/ 

Instagram: https://www.instagram.com/deedeechainey/ 

Paige Dansinger leverages immersive technologies to create innovative, participatory solutions for sustainable smart cities, museums, and communities. Paige is the Director of the XR Women Museum and Gallery. She is the founder of Better World Museum, Horizon Art Museum, and Women in Horizon.  

Anju Bhargava, PhD is a licensed clinical psychologist for Persistent Technology, Inc. (PTI). She’s an expert in digital health, with her work spanning from early ideation and establishing proof of concept, to implementation and regulatory clearance. She’s served as a consultant for PTI for over two years, participating in the design, development, and research of Reflect XR, an Immersive Arts for Wellness tool. She’s a former employee of the Defense Health Agency and Curio Digital Therapeutics.